Composition and its use
A combination of NAD precursors, NAMPT upregulators, and NQO1 upregulators in a composition addresses the limitations of NAD precursor supplementation, effectively increasing NAD levels and mitigating aging effects, including skin conditions and age-related health issues.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- NUCHIDO LTD
- Filing Date
- 2019-03-13
- Publication Date
- 2026-06-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing methods for increasing NAD levels in humans to combat aging, such as supplementation with NAD precursors like NMN and NR, face challenges including high cost, saturation effects, and diminishing efficacy over time, making it difficult to achieve substantial rejuvenation.
A composition comprising a combination of NAD precursors, NAMPT upregulators, and NQO1 upregulators, optionally with NNMT downregulators, is administered to enhance NAD concentration, utilizing a combination of active agents that can be given together or separately in various forms.
The composition effectively increases NAD levels, addressing the limitations of precursor supplementation by enhancing mitochondrial function and reducing the effects of aging, including skin conditions and age-related health issues.
Smart Images

Figure 0007873832000002 
Figure 0007873832000003 
Figure 0007873832000004